Jeffrey Robert Ajer - 07 Apr 2025 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Director
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
Issuer symbol
VRDN
Transactions as of
07 Apr 2025
Net transactions value
$0
Form type
4
Filing time
09 Apr 2025, 16:26:02 UTC
Previous filing
17 Jan 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +42,000 $0.000000 42,000 07 Apr 2025 Common Stock 42,000 $11.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.